The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin

Biochemical Pharmacology

Volumn 57, Issue 4, 1999, Pages 383-386

  Draude, Georg ^a   Hrboticky, Nina ^a   Lorenz, Reinhard L ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arteriosclerosis; Lovastatin; LOX 1; Monocytes; oxLDL; Scavenger receptor

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CATTLE; CONTROLLED STUDY; CYTOCHEMISTRY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICUS;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DOWN-REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LECTINS; LOVASTATIN; MALE; MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, LDL; RECEPTORS, OXIDIZED LDL; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E;

EID: 0032946280     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00313-X     Document Type: Article

References (27)

1. Brown M.S., Goldstein J.S. Lipoprotein metabolism in the macrophage Implications for cholesterol deposition in atherosclerosis . Annu Rev Biochem. 52:1983;223-261.
2. Krieger M. Molecular flypaper and atherosclerosis Structure of the macrophage scavenger receptor . Trends Biochem Sci. 17:1992;141-146.
3. Kodama T., Reddy P., Kishimoto C., Krieger M. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA. 85:1988;9238-9242.
4. Freeman M., Ekkel Y., Rohrer L., Penman M., Freedman N.J., Chisolm G.M., Krieger M. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells Lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein . Proc Natl Acad Sci USA. 88:1991;4931-4935.
5. Rohrer L., Freeman M., Kodama T., Penman M., Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343:1990;570-572.
6. Steinberg D. Low density lipoprotein oxidation and its pathological significance. J Biol Chem. 272:1997;20963-20966.
7. Pitas R.E. Expression of the acLDL receptor by rabbit fibroblasts and smooth muscle cells. J Biol Chem. 265:1990;12722-12727.
8. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as an HDL receptor. Science. 271:1996;518-520.
9. Ramprasad M.P., Fischer W., Witztum J.L., Sambrano G.R., Quehenberger O., Steinberg D. The 94- to 97 kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA. 92:1995;9580-9584.
10. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11811-11816.
11. Sawamura T., Kume N., Aoyama T., Moriwaki H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386:1997;73-77.
12. Raveh D., Israeli A., Arnon R., Eisenberg S. Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins. Atherosclerosis. 82:1990;19-26.
13. Umetami N., Kanayama Y., Okamura M., Negoro N., Takeda T. Lovastatin inhibits gene expression of type I scavenger receptor in THP-1 human macrophages. Biochim Biophys Acta. 1303:1996;199-206.
14. Pietsch A., Erl W., Lorenz R.L. Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Biochem Pharmacol. 52:1996;433-439.
15. Eiermann D.F., Johnson C.E., Haskill S.J. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol. 142:1989;1970-1976.
16. Weber C., Erl W., Pietsch A., Ströbel M., Ziegler-Heitbrock H.W.L., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule 1 in endothelial cells stimulated to generate radicals. Arteriosclerosis Thromb Vasc Biol. 14:1994;1665-1673.
17. Danesch U., Weber P.C., Sellmayer A. Arachidonic acid increases c-fos and Egr-1 mRNA in 3T3 fibroblasts by formation of prostaglandin E2 and activation of protein kinase C. J Biol Chem. 269:1994;27258-27263.
18. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. In vitro cultivation of human tumors Establishment of cell lines derived from a series of solid tumors . Natl Cancer Inst. 51:1973;1417-1423.
19. Ponte P., Ng S.Y., Engel J., Gunning P., Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs DNA sequence of a human beta-actin cDNA . Nucleic Acids Res. 12:1984;1687-1696.
20. Hrboticky N, Draude G, Hapfelmeier G, Lorenz RL and Weber PC, Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized low density lipoproteins in human blood monocytes during the early stage of differentiation into macrophages. Arteriosclerosis Thromb Vasc Biol, in press.
21. Lougheed M., Lum C.M., Ling W., Suzuki H., Kodama T., Steinbrecher U. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem. 272:1997;12938-12944.
22. Van der Kooij M., von der Mark E.M., Kruijt J.K., van Velzen A., van Berkel T.J.C., Morand O.H. Human monocyte-derived macrophages express an approximately 120-kD ox-LDL binding protein with strong identity to CD68. Arteriosclerosis Thromb Vasc Biol. 17:1997;3107-3116.
23. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T., Kostner B., Tomiyama Y., Nakata A., Ishigami M., Miyagawa J., Kameda-Takemura K., Kurata Y., Matsuzawa Y. Reduced uptake of oxidized low-density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 96:1995;1859-1865.
24. Yoshida H., Quehenberger O., Kondratenko N., Green S., Steinberg D. Minimally oxidized LDL increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arteriosclerosis Thromb Vasc Biol. 18:1998;794-802.
25. Vaughan C.J., Murphy M.B., Buckley B.M. Statins do more than lower cholesterol. Lancet. 348:1996;1079-1082.
26. Adachi H., Tsujimoto M., Arai H., Inoue K. Expression cloning of a novel scavenger receptor from human endothelial cell. J Biol Chem. 272:1997;31217-31220.
27. Nagase M., Hirose S., Sawamura T., Masaki T., Fujita T. Enhanced expression of endothelial oxidized low density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun. 237:1997;496-498.